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ABSTRACT We postulate that the inhibition of growth and low rates of mortality of
bacteria exposed to ribosome-binding antibiotics deemed bacteriostatic can be attrib-
uted almost uniquely to these drugs reducing the number of ribosomes contributing to
protein synthesis, i.e., the number of effective ribosomes. We tested this hypothesis with
Escherichia coli K-12 MG1655 and constructs that had been deleted for 1 to 6 of the 7
rRNA (rrn) operons. In the absence of antibiotics, constructs with fewer rrn operons have
lower maximum growth rates and longer lag phases than those with more ribosomal
operons. In the presence of the ribosome-binding “bacteriostatic” antibiotics tetracycline,
chloramphenicol, and azithromycin, E. coli strains with 1 and 2 rrn operons are killed at a
substantially higher rate than those with more rrn operons. This increase in the suscepti-
bility of E. coli with fewer rrn operons to killing by ribosome-targeting bacteriostatic anti-
biotics is not reﬂected in their greater sensitivity to killing by the bactericidal antibiotic
ciproﬂoxacin, which does not target ribosomes, but also to killing by gentamicin, which
does. Finally, when such strains are exposed to these ribosome-targeting bacteriostatic
antibiotics, the time before these bacteria start to grow again when the drugs are re-
moved, referred to as the post-antibiotic effect (PAE), is markedly greater for constructs
with fewer rrn operons than for those with more rrn operons. We interpret the results of
these other experiments reported here as support for the hypothesis that the reduction
in the effective number of ribosomes due to binding to these structures provides a sufﬁ-
cient explanation for the action of bacteriostatic antibiotics that target these structures.
IMPORTANCE Chemotherapeutic agents, including antibiotics, have been used for
more than a century; nevertheless, there are still major gaps in our understanding of
how these drugs operate which limit future advances in antibacterial chemotherapy.
Although the molecular mechanisms by which antibiotics bind to their target struc-
tures are largely known, fundamental questions about how these drugs actually kill
and/or inhibit the replication of bacteria remain unanswered and subjects of contro-
versy. We postulate that for the broad class of ribosome-binding bacteriostatic anti-
biotics, their reducing the number of active (functional) ribosomes per cell provides
a sufﬁcient explanation for the abatement of replication and the low rate of decline
in densities of viable cells of bacteria exposed to these drugs. Using E. coli K-12 con-
structs with deletions of from one to six of the seven ribosome-RNA operons and
the ribosome-binding bacteriostatic antibiotics tetracycline, chloramphenicol, and
azithromycin, we tested this hypothesis. The results of our experiments are consis-
tent with this “numbers game” hypothesis.
Antimicrobial chemotherapeutic agents, as we now know them, have been studiedfor more than a century, since Paul Ehrlich developed arsphenamine, also known
as Salvarsan or compound 606, an organoarsenic drug introduced at the beginning of
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the 1910s for the treatment of Treponema pallidum infections (syphilis) (1). In the course
of this time, many different naturally occurring, synthetic and semisynthetic antibiotics
have been developed and used. For virtually all of these drugs, the molecular structure
and target of action and the molecular basis of the interactions with the target have
been elucidated. The literature abounds with colorful three-dimensional (3D) diagrams
of antibiotics binding to and modifying the structure of their target molecules (see, for
example, references 2, 3, and 4).
Indeed, from reviews of the antibiotic and antibiotic treatment literature, one may
get the impression that, for the vast majority of antibiotics currently employed, we
know virtually all that is meaningful. Arguably, but far from surely, that may well be the
case for the use of these drugs clinically. On the other hand, at a mechanistic level there
are fundamental unanswered questions, such as how bactericidal antibiotics actually
kill bacteria. The controversy about the role of reactive oxygen species (ROS) in the
killing of bacteria by bactericidal antibiotics (5–8) (also see reference 9 for a commen-
tary) is a testimony to the existing knowledge gaps about these mechanisms. One
would assume that, after more than a century of studying antibiotics, there would be
a widely accepted answer(s) to this fundamental question.
Unanswered questions about how antibiotics actually work are not restricted to the
mechanism by which they kill bacteria. Many of the major antibiotic drugs act primarily
by inhibiting the replication of the bacteria and are deemed “bacteriostatic” rather than
“bactericidal.” The majority of bacteriostatic antibiotics employed, including agents
such as chloramphenicol, the tetracyclines, the macrolides (as erythromycin), and the
oxazolidinones (as linezolid), target ribosomes. How these drugs bind to ribosomes, the
binding sites, the kinetics of their associations with these structures (binding rates), and
their effects on protein synthesis and the metabolic rates of bacteria have been
extensively studied (e.g., see references 10, 11, 12, 13, 14, and 15). Nevertheless, it
remains unclear why these ribosome-targeting antibiotics are bacteriostatic and why
their use at low concentrations reduces the growth rates of bacterial populations and
at higher concentrations prevents the growth of and leads to low rates of decline in the
viable cell densities of these populations.
In this report, we present (“venture” may prove a more prudent verb choice) a
general hypothesis that can account for these properties of ribosome-targeting bac-
teriostatic antibiotics. Using constructs of Escherichia coli with different numbers of
rRNA (rrn) operons and bacteriostatic and bactericidal antibiotics of different classes, we
tested this hypothesis. We interpret the results of our experiments as support for this
hypothesis.
RESULTS
A hypothesis for the bacteriostatic and bactericidal activity of ribosome-
binding antibiotics. Our hypothesis for the mechanisms of action of ribosome-binding
bacteriostatic antibiotics is founded on the classical studies of Kjeldgaard and Kurland
(16), Ecker and Schaechter (17), and Davis and colleagues (18) demonstrating that the
rates of growth of bacteria are directly proportional to the number of ribosomes in a
cell. Central to this hypothesis is the assumption that there is a distribution of ribosome
numbers among the members of a population of bacteria (19, 20). In the absence of
antibiotics and in the presence of sufﬁcient nutrients, the population grows at a rate
that depends on the average number of ribosomes contributing to protein synthesis
among its members. In Fig. 1, we illustrate this hypothesis.
The model depicted in Fig. 1A is based on that by Greulich and colleagues (21).
There is a continuous turnover of ribosomes in a cell. The bacteria take up the
antibiotic, which binds to the ribosomes and thereby removes them from the pool of
ribosomes contributing to protein synthesis. As a consequence of this encounter with
these bacteriostatic antibiotics, the average number of “effective ribosomes” borne by
members of the population is reduced. At some rate, the antibiotics dissociate and the
previously drug-bound ribosome becomes effective again (22). We assume a Hill
Levin et al. ®
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function for the relationship between the number of ribosomes borne by a cell and its
growth rate (shown as the black line in Fig. 1B and C) as follows:
(r) (MAX MIN)
r
(r )
 MIN
where MAX ( 0) per cell per unit time is the maximum growth rate, MIN ( 0) is the
death rate,  is the Hill (shape) parameter, and r is the number of ribosomes in a cell.
In the absence of the antibiotic and in the presence of nutrients, the vast majority
of the population has a sufﬁcient number of ribosomes to replicate and the population
grows (the blue line in Fig. 1B). If the average number of effective ribosomes is reduced
(the green distribution in Fig. 1B), the population can still replicate but does so at a rate
lower than that which obtains with a higher average number of ribosomes (Fig. 1B). By
further lowering the number of effective ribosomes which is anticipated due to binding
by bacteriostatic antibiotics, the net growth rate of the population at large becomes
negative (the red line in Fig. 1B, and Fig. 1C). Depending on their number of effective
ribosomes, individual cells would either be dividing or dying. In Fig. S1 in the supple-
mental material, we use a stochastic simulation for a numerical illustration of the
relationship between the distribution of ribosome numbers among cells and the
growth/death rate of the population (r) as depicted in Fig. 1B and C.
Predictions. There are three testable (and rejectable) predictions:
(1) A reduction in the average number of ribosomes would be made manifest by
a lower maximum growth rate for the population at large.
(2) When the average number of ribosomes is further reduced, ribosome-binding
bacteriostatic antibiotics become increasingly bactericidal.
(3) Because of the binding of the antibiotic to and dissociation of the antibiotic
from the ribosomes, the extent to which bacteriostatic antibiotics reduce the
growth rate and kill would be proportional to the concentration of the drug.
If we further assume that (i) the transition from non-growth to growth when
populations are provided with fresh media requires the production of a speciﬁc number
of new, functional ribosomes and (ii) the time required to achieve that number is
FIG 1 A model for the numbers game hypothesis for the action of ribosome-binding bacteriostatic
antibiotics. (A) Turnover of ribosome (the green “shmoos”). The dashed circle with an arrow represents
degradation and replacement (biogenesis) of ribosomes in a cell. The red diamonds represent antibiotics
entering the cells and binding to and being released from the ribosomes. (B) Growth rate and death rate
as functions of the number of ribosomes (the black line) (a Hill function; see the text). When the number
of ribosomes is in the shaded area, cells die at a low rate. The blue, green, and red lines are normal
distributions for the fraction of the population with the corresponding number of functional (not bound
to drug) ribosomes. (C) Blow-up, growth, and death when the average number of ribosomes is low.
Ribosome Numbers and Antibiotic-Mediated Stasis and Death ®
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inversely proportional to the average number of functional ribosomes borne by mem-
bers of the population in that static state, there are two additional predictions:
(1) In the absence of antibiotics, a reduction in the average number of ribosomes
would be manifest by an increase in the length of time before a stationary-
phase population starts to grow when fresh resources are made available (the
lag phase).
(2) When stasis is due to the presence of ribosome-binding antibiotics, a reduction
in the average number of functional ribosomes would be reﬂected as an
increase in the time before the population grows after the antibiotics are
removed and fresh resources are made available (the post-antibiotic effect
[PAE]) (23).
Ribosome operon deletion strains and numbers of ribosomes. To test the
validity of these predictions and thereby the ribosome number hypothesis for the
action of ribosome-binding bacteriostatic antibiotics, we used a set of E. coli K-12 strains
constructed by S. Quan and colleagues (24, 25) with deletions of from 1 to 6 of the 7
E. coli rRNA (rrn) operons (designated D1 to D6) and the E. coli MG1655 strain
(designated MG) from whence they were derived. In an effort to determine the
relationship between the number of ribosome (rrn) operons and the number of
ribosomes, we used a Bioanalyzer to estimate the relative amounts of 16S and 23S rRNA
per unit of total cell RNA of these deletion strains. The results of this analysis for three
independent RNA extractions from 24-h stationary-phase cultures of MG1655 and the
6 rrn operon deletion strains are depicted in Fig. S2.
We interpret the results of this analysis to be consistent with the hypothesis that,
under the conditions of these experiments (E. coli grown at 37°C in glucose minimal
medium supplemented with 0.2% casein amino acids), the number of ribosomes is
proportional to the number of ribosomal operons; constructs with fewer rrn operons
have fewer ribosomes. There is a signiﬁcant increase in the fraction of 16S rRNA and 23S
rRNA with increasing numbers of rrn operons. It should be noted, however, that a linear
relationship between the number of rrn operons and the amount of rRNA is not
expected, because of the higher expression of the remaining rrn copies in rrn operon-
deleted mutants (26).
Ribosome numbers and rates of growth and time of lag. In accord with the
hypothesis depicted in Fig. 1 and the predictions based on this model, when the average
number of ribosomes is sufﬁciently high, the rate of growth of the bacteria is predicted to
be relatively independent of that number. When the number of ribosomes is further
reduced, the rate of growth of the bacteria is predicted to decline and become increasing
proportional to the number of ribosomes. The results of studies estimating the growth rates
of E. coli in lysogeny broth (LB) (24, 27) support these predictions.
To obtain a broader perspective on the effects of deletions of ribosomal operons
(which we use as a proxy for the average number of ribosomes) on the dynamics of
growth of E. coli and on the robustness and generality of the results reported in
references 24 and 27, we used a Bioscreen automated plate reader to follow the
changes in the optical densities of growing populations of E. coli for 20 h or more. The
bacteria were incubated at 37°C and continuously shaken, with optical densities (ODs)
at 600 nm estimated every 5 min. In these experiments, we used the medium (glucose
minimal medium supplemented with 0.2% casein amino acids) employed for the
16S-23S RNA assay whose results are presented in Fig. S2 and in the experiments that
follow. Estimates of the maximum growth rates (the Malthusian parameters [MP]) and
the lengths of lags as functions of the number of rrn operons are depicted in Fig. 2.
There was no apparent effect on the maximum growth rate, MP, when the number of
rrn operons was 4 or greater [F(3,121) 1.56] (P 0.203). The MP values of the constructs
with fewer than 3 rrn operons were substantially lower than the MP values of those with
more [F(2,92)  45.32] (P  0.0001). The apparent greater MP of the constructs with 2 rrn
operons than of those with 3 [F(1,63)  6.9] is statistically signiﬁcant (P  0.011), but the
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difference is negligible. The most profound effect of ribosome operon numbers on maxi-
mum growth rate is seen for the construct with only 1 rrn operon, for which the value is
only 57 percent as great as the value for those with 2 rrn operons.
The length of the lag declines with the number of ribosomal operons (Fig. 2B). For
the constructs with from 2 to 7 rrn operons, the relationship between the lag and the
number of rrn operons is roughly linear, with a highly signiﬁcant slope (P  0.00010),
for 188 degrees of freedom: P(17.0    13.6)  0.95. The length of the lag phase
increased precipitously for the construct with 1 rrn operon.
Ribosome numbers and the bactericidal effects of bacteriostatic antibiotics. In
accord with the ribosome number hypothesis for the static and cidal activity of
bacteriostatic antibiotics that bind to these structures, the expression of a critical
number of vital proteins is needed to sustain cellular life. Consequently, if the average
number of ribosomes contributing to protein synthesis is reduced, these drugs should
become increasingly bactericidal. To test this hypothesis, we exposed MG1655 and the
constructs with deletions of from 1 to 6 rrn operons to 25, 125, and 40 g/ml of
tetracycline (TET), chloramphenicol (CAM), and azithromycin (AZI), respectively. As our
measure of the susceptibility of these strains to killing by these drugs, we used the
hourly rate of growth/death, , calculated from the viable cell densities (CFU data) of
growing cultures immediately before exposure to the antibiotics, N(0), and after 24 h of
exposure, N(24), as follows: i 
1
24
ln N24
N0
. The estimates of N(0) and N(24) for
these calculations were the mean values estimated from three (and occasionally two)
separate serial dilutions and platings.
The results of a compendium of from 7 to 10 of these time-kill experiments are
presented in Fig. 3A. As measured by the rate of kill of these antibiotics, , constructs
FIG 2 Rates of growth and lengths of lags for E. coli as a function of numbers of ribosomal (rrn) operons estimated from
changes in optical density (600 nm Bioscreen) and CFU data. (A) Means and standard errors of the maximum growth rates (the
Malthusian parameter [MP]). (B) Means and standard errors of the length of the lag. (C) Functional relationship between the
length of the lag phase and the number of ribosomal operons for MG1655 and constructs with 2 to 6 rrn operons. Data were
compiled from separate Bioscreen runs with a minimum of 20 points for each strain.
Ribosome Numbers and Antibiotic-Mediated Stasis and Death ®
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with only 1 and 2 rrn operons are considerably more susceptible to killing by these
drugs than those with more rrn operons. The concentrations of antibiotics used in the
experiments whose results are presented in Fig. 3A were chosen because they were
substantially above the MICs of these antibiotics for these E. coli constructs (Table S1)
and for susceptible E. coli as a species (28). In Fig. 3B, we present estimates of  for a
compendium of from 2 to 4 time-kill experiments run with different concentrations of
these “bacteriostatic” antibiotics. These experiments provide evidence that the con-
structs with 1 and 2 ribosomal operons, D5 and D6, are more susceptible to killing by
these drugs than those with more rrn operons. As expected, these results also indicate
that the rate of killing by these “bacteriostatic” antibiotics and particularly by tetracy-
cline increases with the concentration of the drug (29).
Ribosome numbers and the susceptibility of E. coli to bactericidal antibiotics.
The preceding results support the hypothesis that reductions in ribosome numbers
make E. coli more susceptible to killing by the ribosome-targeting bacteriostatic
antibiotics (tetracycline, chloramphenicol, and azithromycin) and that this bactericidal
effect is proportional to the concentration of the antibiotic. There is, however, a caveat
that has to be addressed: to wit, that reductions in ribosome numbers make E. colimore
susceptible to antibiotic-mediated killing for reasons other than the numbers of
ribosomes. In accord with this caveat, antibiotics that do not act by binding to
ribosomes would also be more bactericidal when the average number of ribosomes is
FIG 3 Susceptibility to killing by ribosome-targeting bacteriostatic antibiotics. (A) Hourly growth/death rates for exponentially growing MG1655
(MG) and constructs with from 0 to 6 ribosomal rrn operon deletions (MG and D1 to D6) exposed to 25, 125, and 40 g/ml of tetracycline (TET),
chloramphenicol (CAM), and azithromycin (AZI), respectively. (B to D) Hourly growth/death rates of E. coli MG1655 and constructs with 7, 6, 3,
2, and 1 rrn operons (respectively, MG, D1, D4, D5, and D6) exposed to different concentrations of tetracycline, chloramphenicol, and
azithromycin before the growing cultures were exposed to the drugs and after 24 h of exposure. The results shown in panel A represent the
means and standard errors of the estimates of  for from 7 to 10 independent experiments of this growth/death rate parameter, and those
shown in panel B represent the means and standard errors of the estimates of  for from 2 to 4 independent experiments.
Levin et al. ®
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reduced. To test this, we performed time-kill experiments similar to those described
above using the bactericidal antibiotic ciproﬂoxacin, which acts on DNA synthesis (30)
rather than ribosomes, and also gentamicin, which does target ribosomes (31).
The results of this experiment are presented in Fig. 4. This experiment suggests that
there is either no relationship between the susceptibility of the strains with fewer
ribosomal operons and killing by these bactericidal antibiotics or, possibly, lower
sensitivity of the construct with 1 ribosomal operon. See the Discussion for a consid-
eration of why this might be the case.
Postantibiotic effects. The increase in the lag with increases in the number of rrn
operon deletions (reductions in the number of ribosomes) (Fig. 2) is also what would
be anticipated from the model depicted in Fig. 1. To come out of stationary phase, the
bacteria have to produce a sufﬁcient number of functional ribosomes to replicate. In
this interpretation, those that had fewer ribosomal operons and would thereby start
with lower numbers of ribosomes would take longer to reach the threshold number of
ribosomes required for replication. Exposure to antibiotics also increases lags. Although
the resources needed for replication abound and the bacteria are not at stationary
phase, there is a period of time after antibiotics are removed before the population
starts to grow. One interpretation of the increased lag following exposure to these
drugs, i.e., of this post-antibiotic effect (PAE) (23), for ribosome-binding bacteriostatic
antibiotics is that as a consequence of binding to these structures, the average number
of effective ribosomes is reduced and more unbound ribosomes have to be produced
before the population grows compared to a corresponding population not exposed to
these drugs (32, 33). In this interpretation, reductions in the average number of
ribosomes would further augment the length of the PAE.
To test this hypothesis, we estimated the length of the PAE for the ribosome-
targeting bacteriostatic antibiotics considered here for MG1655 and E. coli constructs
deleted for 1, 4, 5, and 6 rrn operons (D1, D4, D5, and D6, respectively). The details of
the protocol are presented in Materials and Methods. The results of a compendium of
three of these PAE experiments are presented in Fig. 5.
As suggested by the magnitude of the standard errors, there was considerable
variation among the results of the experiments in the estimates of the PAEs and
particularly that for chloramphenicol and strain D6 with 1 rrn operon. Be that as it may,
these results certainly suggest that the lengths of the PAE for the constructs with fewer
rrn operons, D4, D5, and D6, are greater than the lengths of the PAE for those with more
rrn operons, MG and D1.
DISCUSSION
By binding to these macromolecular complexes, ribosome-targeting bacteriostatic
antibiotics reduce the number of ribosomes contributing to protein synthesis. We
postulate that this reduction in the average number of effective ribosomes is a
FIG 4 Hourly rates of decline in the viable cell density of growing cultures of MG1655 and constructs
with 6, 3, 2, and 1 rrn operons (respectively, D1, D4, D5, and D6) exposed to 10 g/ml gentamicin and
0.75 g/ml ciproﬂoxacin. Data represent means and standard errors of the kill rates (i) determined for
2 or 3 separate experiments.
Ribosome Numbers and Antibiotic-Mediated Stasis and Death ®
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sufﬁcient explanation for the abatement of growth (stasis) and the low rate of decline
in the viable cell densities of populations of bacteria exposed to ribosome-targeting
bacteriostatic antibiotics. By the word “sufﬁcient” we are proposing that the mode of
action of these antibiotics is essentially a ribosome “numbers game” and that it is not
necessary to assume that other processes are involved.
We interpret the results of our experiments performed with E. coli MG1655 and
constructs deleted for 1 to 6 of the 7 ribosomal operons as evidence in support of this
numbers game hypothesis for the action of ribosome-targeting bacteriostatic antibi-
otics. As anticipated by this hypothesis and observed in our experiments, three
predictions have been met. (i) When exponentially growing populations of E. coli are
exposed to supra-MICs of the ribosome-targeting bacteriostatic antibiotics tetracycline,
chloramphenicol, and azithromycin, the rate at which constructs with 1 and 2 ribosomal
operons are killed is substantially greater than that for those with more rrn operons. (ii)
This greater sensitivity of constructs with 1 and 2 rrn operons to killing by bacteriostatic
antibiotics is not manifest by their being more susceptible to killing by ciproﬂoxacin,
which does not target ribosomes. (iii) The length of the lag following removal of the
antibiotic (the post-antibiotic effect [PAE]) is greater for constructs with only 1 or 2 rrn
operons than for constructs with more rrn operons.
Central to this interpretation of our experiments is the proposition that the average
number of ribosomes borne by cells is proportional to the number of ribosomal RNA
operons. The observation that the fraction of 16S RNAs and 23S RNAs declines in
proportion to the number of rrn operon deletions is consistent with this proposition.
Also consistent are the growth dynamic data presented in this report (Fig. 2) and in
reference 24, along with classical studies of the rates of growth of E. coli and the
numbers of ribosomes reported by Kjeldgaard and Kurland (16), Ecker and Schaechter
(17), and Davis and colleagues (18).
On ﬁrst consideration, it may seem that the observation that constructs with 1 and
2 ribosomal operons are not killed by the ribosome-targeting, bactericidal antibiotic
gentamicin at a rate different from the rate seen with those with more ribosomal
operons (Fig. 4), may seem inconsistent with this numbers game hypothesis. We
suggest this is not the case. Even if there were a contribution of ribosome numbers to
the rate of kill of the magnitude observed for the bacteriostatic antibiotics and
constructs with 1 and 2 rrn operons, it would be hard to detect this effect for bacteria
exposed to supra-MICs of gentamicin. The maximum rate of killing of a construct with
6 rrn operons by bacteriostatic antibiotics is on the order of 0.30 per h, which
obtained at approximately 80, 33, and 32 MIC for tetracycline, chloramphenicol,
and azithromycin, respectively. At approximately 4 MIC, the rate of gentamicin-
mediated kill is on the order of 7.0 per h.
If anything, this difference in the kill rate of gentamicin relative to those of the
ribosome-targeting bacteriostatic drugs supports the hypothesis that when bacteria are
exposed to supra-MICs of this aminoglycoside, processes other than the reduction in the
FIG 5 Post-antibiotic effect (PAE) for MG1655 (MG) and constructs with 6, 3, 2, and 1 rrn operons (D1,
D4, D5, and D6, respectively) exposed to 25, 125, and 40 g/ml of tetracycline (TET), chloramphenicol
(CAM), and azithromycin (AZI), respectively. Data represent differences between the estimated lag values
determined following exposure to the antibiotics and those observed in the absence of these drugs.
Means and standard errors of PAEs for three separate experiments are shown.
Levin et al. ®
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number of effective ribosomes, such as a “surface-cidal effect” (34, 35), are responsible for
the high rate at which bacteria are killed by these drugs. The possibility of ribosomes
producing an “binding sink effect” with respect to aminoglycosides, massively increasing
drug uptake (energy-dependent phase II) and resulting in a collapse of proton motive force
and, ﬁnally, lethal cell membrane damage, is certainly of interest (36, 37). Reductions in the
number of ribosomes in strains with increasing numbers of rrn operon deletions will
decrease the binding sink effect and thus aminoglycoside uptake, such that deletions
would decrease rather than increase the rate at which supra-MIC concentrations of ami-
noglycosides kill bacteria. Similarly, as a consequence of having fewer ribosomes, we would
anticipate a reduction in the absolute number of mistranslated and misfolded proteins and
thus a lower rate of production of the toxic compounds that are considered to be
responsible for killing bacteria exposed to gentamicin or other aminoglycosides (5, 38–40).
Moreover, because the rate of replication would be reduced, there should be less misread-
ing. For example, rpsL mutations increase the ﬁdelity of protein synthesis by reducing the
rates of protein elongation and thereby allowing for more error correction.
Consistent and sufﬁcient. We interpret the results of these experiments to be
consistent with and thereby provide support for the ribosome numbers game hypoth-
esis for the mechanisms of action of ribosome-targeting bactericidal antibiotics. We
recognize that there may be more to the association between rrn operon numbers and
the susceptibility of bacteria to killing by ribosome-targeting bacteriostatic antibiotics
and the length of the post-antibiotic lag (PAE) than simple reductions in the effective
number of ribosomes as suggested by our model. Moreover, processes other than
removing ribosomes from the effective pool by binding can account for these drugs
reducing the number of ribosomes contributing to protein synthesis. Most prominent of
these other mechanisms is that of binding to these macromolecules, these antibiotics also
inhibit the biogenesis of new ribosomes (10, 11, 41). That is, as a consequence of reducing
rates of protein synthesis, there is imbalance in the production of ribosomal components
(42). With respect to our model, this would be another reason that bacteriostatic antibiotics
that target these macromolecules would reduce their effective numbers.
It should be noted that the model depicted in Fig. 1 makes a prediction about the
mode of action of ribosome-targeting bacteriostatic antibiotics that is independent of
the ribosome number elements of this hypothesis. It predicts that when growing
populations of bacteria are confronted with these drugs, a fraction of the population
will be replicating at a low rate and another fraction will be dying. While this hypothesis
cannot be tested with population-level data of the sort employed here, it can be tested
and rejected by following the fate of individual cells in growing cultures exposed to
ribosome-targeting antibiotics.
Mechanisms and mechanisms and unanswered questions. At one level, the
postulated reduction in the average number of effective ribosomes represents a
mechanism explaining how ribosome-targeting antibiotics arrest the growth, reduce
the metabolic rate, and increase the rate of decline in viable cell density of bacteria
exposed to these agents. However, as an explanation of the mode of action of ribosome-
binding bacteriostatic antibiotics, the postulated “numbers game” is no more complete
than mistranslation producing “toxic” compound explains how, when exposed to
ribosome-targeting bactericidal antibiotics, bacteria are killed at a high rate; it is still
necessary to account for how these “toxins” kill (5, 9). A comprehensive mechanistic
explanation for the action of ribosome-targeting bacteriostatic drugs requires more
quantitative information about the dynamics of ribosome degradation and production,
the binding and release of the antibiotics, and the relationship between protein
synthesis and other factors contributing to the rates of growth and death of bacteria.
It was classically proposed that, as temporary arrest of bacterial protein synthesis is
not per se lethal, inhibitors of protein synthesis are bacteriostatic if they do not form
irreversible bonds with the ribosome and that, if they do, they are bactericidal (43).
Consistent with this interpretation and this ribosome numbers game hypothesis is the
synergy between ribosome-binding antibiotics of different types (44). However, the
Ribosome Numbers and Antibiotic-Mediated Stasis and Death ®
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validity of this statement about binding has not been fully demonstrated; the advent
of ribosomal crystallography and nuclear magnetic resonance for the study of the
interaction of antibiotics with the ribosome (45) has shown that macrolides that bond
to the ribosome leave the complex very slowly, whereas aminoglycosides, being
reversible binders, are more highly cidal drugs. Certainly, we need more data on the
proteome of bacterial cells confronted with ribosome inhibitors to better address to
this issue. As with a recent published, elegant, jointly theoretical and experimental
study of the growth-dependent action of ribosome-targeting antibiotics (21), at this
juncture the numbers game hypothesis presented here is arguably more phenomeno-
logical than fully mechanistic.
Be that as it may, the numbers game hypothesis presented in this study may have
practical implications in chemotherapy. In contrast to what is generally assumed for
antimicrobial agents and is certainly true for bactericidal drugs, bacteriostatic antibiotics
might increase rather than decrease their efﬁcacy in slowly growing bacterial populations.
This hypothesis suggests that bacteriostatic drugs kill a greater fraction of the treated
bacterial populations under certain cellular conditions that are expected to occur in vivo,
such as a shortage of nutrients, than under in vitro conditions. Could there be sites of
infection where, because of the distribution of ribosome numbers of the infecting bacteria,
antibiotics that are considered bacteriostatic are bactericidal? Could this be the reason or
part of the reason that bacteriostatic antibiotics targeting ribosomes are as effective
clinically for treating acute infections as bactericidal drugs (46, 47)? Do the intracellular
concentrations of such static agents as macrolides, tetracyclines, or chloramphenicol (in the
range of those used in our experiments) inﬂuence the expected intracellular bacteria with
lower ribosome numbers? Could the distribution of ribosome numbers be the reason why
bacteriostatic antibiotics are effective (and are frequently the drugs of choice) for treating
infections by mostly intracellular bacteria with lower rrn operon copies, including Campy-
lobacter, Legionella, Brucella, and Bordetella (all of which have 3 rrn operon copies), Chla-
mydia and Helicobacter (2 copies), and Mycoplasma, Coxiella, Rickettsia, and Mycobacterium
avium-M. intracellulare (1 single rRNA gene copy) (48, 49)? As can be seen in the example
in Fig. S3, erythromycin and chloramphenicol, antibiotics that are deemed bacteriostatic for
E. coli, are strongly bactericidal for another bacterial species, such as Campylobacter jejuni,
which has 3 rrn operons rather than the 7 of E. coli.
Finally, we cannot discard the possibility of using bacterial mutants with low
ribosome numbers in screening tests of natural or synthetic compounds to detect new
ribosome-acting agents (eventually with higher cidal activity) or of studying the
possibility of increasing the bactericidal effect of hitherto bacteriostatic antibiotics,
eventually targeting more effectively ribosome subunit assembly (50).
Coda: hypotheses are to be tested, modiﬁed, and expanded upon, not cham-
pioned.While there has been a great deal of impressive research on the molecular and
structural biology of antibiotic action, the mechanisms by which these drugs actually
kill bacteria and/or inhibit their replication remain largely unknown and subjects of
controversy. It may well be that the “numbers game” hypothesis for the abatement of
growth and low rate of decline in viable cell density of bacteria exposed to ribosome-
targeting bacteriostatic antibiotics presented here will be modiﬁed and expanded upon
by additional models and experiments. We “venture” this hypothesis because it is
compelling a priori, because it has the virtue of parsimony, and because it is supported
by the results of experiments that could have rejected it. We also see it as a path to
address this issue of the mode of action of ribosome-targeting bacteriostatic antibiotics
and to obtain a fully mechanistic answer (or answers).
MATERIALS AND METHODS
Bacteria. For detailed information about the ribosomal operon and rrn deletion strains developed by
S. Quan and colleagues, see Table 1. For detailed genetic information about these strains, see refer-
ences 24 and 25. These strains were obtained from two sources, the E. coli Genetic Stock Center at Yale
University and Ole Skovgaard at Roskilde University in Denmark.
Medium. Difco Davis minimal medium Ca (casein amino acids)—designated DMCa—is composed of
1 g (NH4)2SO4, 3 g KH2PO4, 7 g K2HPO4, and 0.5 g sodium citrate (Na3C6H5O7).
Levin et al. ®
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After autoclaving, the following were added to 1 liter of that medium: 100 ml 2% casein amino acids
(Difco), 1 ml 1% vitamin B1, 1 ml 1% Mg2SO4, and 1 g glucose.
Antibiotics, sources, and MICs. The sources and antibiotics were as follows: from Sigma, tetracycline
hydrochloride (TET), chloramphenicol (CAM), and gentamicin (GEN); from AppliChem, ciproﬂoxacin (CIP);
and from Tocris Bio-Techne, azithromycin (AZI).
The MICs of these antibiotics were estimated by the standard factor-of-2 serial dilution protocol (28)
but in DMCa. The MICs are listed in Table S1 in the supplemental material for MG1655 and the rrn operon
deletion strains.
Sampling. Lysogeny broth agar (Difco) was used for sampling.
Extraction of RNA and estimation of the fraction of 16S and 23S RNA. RNA was isolated from
overnight DMCa cultures of the rrn operon deletion strains using a PureLink minikit and an on-column
PureLink DNase treatment kit, both from Life Technologies, Inc. The relative fractions of 16S and 23S RNA
in the extracted RNA were estimated with an Agilent 20100 Bioanalyzer by the Emory University
Integrated Genomics Core (EIGC) facility.
Estimates of the maximum growth rates and lags. Overnight cultures were diluted to ~5  105
cells per ml in DMCa. A 300-l volume of the cell suspensions was added to the wells of 100-well
Bioscreen plates. The plates were continuously shaken, and the optical densities were determined (at
600 nm) every 5 min. As noted in reference 51, using initial densities of 5  105 CFU/ml, the turbidity of
the culture at time zero was undistinguishable from that of uninoculated medium, thereby enabling us
to normalize the densities by subtracting the time zero OD for each well, rather than using a blank. The
exponential growth rates (the Malthusian parameters [MP]) of these cultures were estimated as the
maximum slope of the natural logarithm of the optical density as a function of time. Speciﬁcally, the MP
was estimated as the greatest slope calculated over ﬁve consecutive points (a time span of 25 min), after
the normalized OD reached 0.02, as suggested in reference 51.
The lag is deﬁned here as the extent of time before there is a net increase in cell density. We are
assuming that, prior to that time, the viable cell density of the population was constant. And we are
further assuming that, immediately following the lag, at time tlag, the population was growing at its
maximum rate (r) per cell per hour. Thus, if N(0) and N(t) are the cell densities at initiation of the
experiment and after t hours, respectively, if t* is the time required for the population to reach a
threshold density N*, the lag phase can be calculated as
tlag t*
1
r
log
N*
N0 (1)
For our estimate of N(0) for this calculation, we use the CFU estimate of density of the culture at the
start of the experiment, when the wells were ﬁlled. As our estimate of the threshold density, N*, we use
the results of an experiment performed with MG1655 and the 6 rrn deletion strains growing exponen-
tially in the experimental media in the Bioscreen. In this experiment, we estimated the CFU density of the
cultures when the optical density (at 600 nm) in wells of the Bioscreen was 0.02. As our estimate of
the CFU densities (N*) of the cultures at an optical density of 0.02, we use the mean CFU estimate of the
densities of all 7 cultures at an optical density of 0.02, or approximately 107 cells per ml. For example, if
a culture was growing at a rate of r  0.025 per cell min, if N(0)  2  105 cells per ml, and if an OD
(600 nm) of 0.02 (a CFU density of 107 cells per ml) was reached at t*  250 min after the start of the
experiment, from equation 1, the estimated lag (tlag) would be 93.5 min.
Time-kill experiments and estimating growth rates/death rates (). The bacteria were grown
overnight in DMCa. These cultures were diluted in this media and allowed to grow for 2.5 h, at which
time 2 ml or 2.5 ml of the cultures was placed into the wells of 12-well or 24-well Falcon polystyrene
plates. The antibiotics were added at the noted concentrations. These plates were incubated with
shaking. At deﬁned intervals, 100-l samples were taken and viable cell densities were estimated from
CFU data by diluting and plating the samples on LB agar.
For the bacteriostatic drugs (Fig. 3), samples were taken at time zero and at 24 h and three
independent estimates of the viable cell density were made for each sample. For our estimates of the
rates of growth and antibiotic-mediated killing by the bactericidal drugs (Fig. 4) samples were taken at
relatively short intervals that differed among the drugs, 0.75 and 1.5 h for ciproﬂoxacin and 0.5 and 1 h
for the gentamicin. The hourly rates of growth/death of these cultures (), calculated from the viable cell
densities (CFU data) of growing cultures immediately before exposure to the antibiotics, N(0), and after
TABLE 1 Ribosomal operon and rrn deletion strains developed by S. Quan and
colleagues
E. coli strain
(Quan SQ notation)
Designation
in this study
SQ37 D1
SQ40 D2
SQ49 D3
SQ78 D4
SQ88 D5
SQ110 D6
MG1655 (ancestor) MG
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24 h of exposure, N(24), were determined as follows: i 
1
24
ln N24
N0
. The estimates of N(0) and
N(24) for these calculations were the mean values estimated from three (and occasionally two) separate
serial dilutions and platings.
Post-antibiotic effects. Fresh overnight cultures of the strains were diluted 1/100 in fresh DMCa and
incubated at ~2 h and 37°C with shaking. At that time, four cultures were prepared for each strain, one
each with azithromycin, chloramphenicol, or tetracycline at 40, 125, or 25 g/ml, respectively, and one
as an antibiotic-free control. After 3 h of incubation at 37°C with shaking, all the cultures were plated in
triplicate to estimate the viable cell (CFU) densities. For each antibiotic and the controls, three sets of
cultures were prepared to measure their growth dynamics in a Bioscreen using ﬁve wells for each of the
cultures. (i) For the washed antibiotic-exposed cells, the antibiotic-exposed cultures were diluted 1/1,000
in fresh media, which brought the antibiotic concentration to about 0.005 the azithromycin, chloram-
phenicol, or tetracycline MIC (0.04, 0.125, or 0.025 g/ml, respectively) (antibiotic-exposed cultures). (ii)
For the antibiotic controls, unexposed cells were diluted 1/10,000 in fresh media with 0.005 the MIC of
the antibiotics. These antibiotic controls are employed to determine the effects on lag of the residual
drugs in the washed antibiotic-exposed cultures. (iii) For the controls, unexposed cells were diluted
1/10,000, 1/100,000, or 1/1,000,000 in fresh media to cover the range of cell densities in the washed
antibiotic-exposed cultures.
Using the above-described method, we estimated the lag of (i) the washed antibiotic-exposed cells
in fresh medium (LagW), (ii) the control cultures with 0.005 MIC of the antibiotic (LagCA), and (iii) the
antibiotic-free control cultures (LagC). The post-antibiotic effect (PAE) is deﬁned as the difference
between LagW and the largest value among the LagCA and LagC results. This gives a conservative
estimate of lag. Save for the method employed to estimate the lag, which controls for possible
differences in growth rates, the procedure to estimate the PAE in these experiments is similar to that
described in reference 52.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mBio.02253-16.
FIG S1, TIF ﬁle, 0.5 MB.
FIG S2, TIF ﬁle, 0.5 MB.
FIG S3, TIF ﬁle, 0.4 MB.
TABLE S1, DOCX ﬁle, 0.01 MB.
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